Search
Research outputs
Histology and molecular characteristics of pregnancy associated breast cancer
[2015]
Tomasevic, Z.; Milovanović, Zorka 
; Tomasevic, Z.M.; Bozovic, Spasojevic I.; Milosevic, S.; Zdrale, Z.; Andjelic, Dekic N.; Kovac, Z.
EPROPA: The European program for routine testing of patients with advanced lung cancer [2021]
Passiglia, F; ...; Secen, Nevena M; ...; (broj, koautora 20)Survey on the Unmet Needs of Patients Living with mCRC Learnings from an International Study [2019]
Maravic, Zorana; Rawicka, Iga; Lemmens, Liesbeth; Bokros, J; Gonzalez, de Pedro C; Stanisic-Trenevski, Jadranka; Mendez, Otero M; Rial, O; Ferro, TA pilot study of combined biomarker-based treatment strategies in patients with recurrent/metastatic squamous cell carcinoma of the cervix: RAIDS molecular targets trial for cervical cancer [2020]
Roufai, Bello D; Sadozye, A; Glasspool, RM; Limaye, S; Mandic, Aljosa D ; Popovic, Marina; Ottevanger, N; Roxburgh, P; Lecuru, F; Cherif, L Larbi;
Kamal, Maud; Le, Tourneau C; Rouzier, Roman; Scholl, Suzy M;
ICES (International Carboplatin Emesis Survey) for the evaluation of the emetogenicity of carboplatin-based chemotherapy - with a focus on nausea. MASCC Antiemetic Study Group survey [2020]
Smit, Teresa; Chan, A; Chasen, Martin Robert; Bhargava, Ravi; Bosnjak, Snezana M; Zilic, Ana; Chia, JT; Jabbar, Adnan Abdul; Yaxiong, Z; De, Necker Margreet;
Mhazo, Tina V; Heyman, Liezl; Rapoport, BL;
R-CHOP vs R-EPOCH in diffuse large B-cell lymphoma CSIIBULKY-IV. The Serbian study lymphoma group (SLG) experience [2008]
Mihaljevic, Biljana S; Andjelic, Bosko M; Jankovic, Snezana D; Milosevic, Violeta S; Sretenovic, Aleksandra M; Markovic, Olivera B ; Djurdjevic, Predrag M ; Jakovic, Ljubomir R ; Perunicic, Maja D; Colovic, Natasa R ;
Petrovic, Milan D; Boskovic, Darinka V;
HERIZON overall survival results: A study of IMU-131, a HER2 targeting peptide vaccine, plus standard of care chemotherapy in patients with HER2 overexpressing metastatic or advanced gastric/GEJ cancer
[2022]
Maglakelidze, Marina; Ryspayeva, D; Andric, Zoran G ; Petrovic, Zeljko M; Bulat, IV; Nikolic, Ivan V ; Chawla, T; Nagarkar, R; Wiedermann, Ursula; Blumenstein, BA;
Chong, LMO; Ede, NJ; Nixon, B; Good, AJ;
POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC) [2024]
Lu, S; Vynnychenko, O; Kulyaba, Y; Kuchava, V; Ibrahim, A; Moiseenko, FV; Arslan, C; Nguyen, DT; Zhang, M; Petrovic, MD;
Cicin, I; Bibichadze, K; Cil, T; Cornfeld, M; Tian, C; Munteanu, M; Sette, CVDM; Bondarenko, I;
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2010]
Eckel, F; Brunner, T; Jelic, Svetislav BPhase IV study of afatinib as second-line therapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring common epidermal growth factor receptor (EGFR) mutations (Del19 and/or L858R) [2015]
Thongprasert, Sumitra; ...; Jovanovic, D; ...; Petrovic, M; ...; Radosavljevic, Davorin Z; Perin, Branislav M; ...; (broj, koautora 19)Filters
By type
- 315